MassDevice6h
Globus Medical beats Street in Q4, stock dips as analysts question Nevro buy
Globus Medical (NYSE:GMED) shares dipped today despite fourth-quarter results that came in ahead of the consensus forecast.
Globus Medical targets $2.8B-$2.9B revenue in 2025 with Nevro acquisition integration
Q4 2024 Management View CEO Daniel Scavilla highlighted record revenue of $2.519 billion for 2024, driven by $951 million in growth and a 61% increase versus the prior year. Non-GAAP EPS for the year ...
FierceBiotech11d
Globus Medical to buy neurostim developer Nevro for $250M
Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...
Orthopedics This Week3d
Globus Medical Pays 38% Premium for Nevro
Globus Medical will acquire Nevro in an all-cash transaction. Both company boards of directors have unanimously approved the ...
Globus Medical: Some Caution After Its Deal For Nevro
Globus Medical started 2025 on a solid note, but a deal for loss-making Nevro creates some discomfort among investors. Read ...
Globus Medical to buy California life sciences firm for $250M
The CEO of Globus Medical said the deal will enable the Audubon company to expand into new markets for future growth.
Nasdaq15d
Globus Medical to Acquire Nevro Corp. in All-Cash Transaction Valued at $250 Million
Globus Medical will acquire Nevro for $250 million in cash, enhancing its musculoskeletal technology portfolio andglobal marketreach. Globus Medical and Nevro Corp. have agreed on an ...
medtechdive15d
Globus to buy Nevro for $250M
Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...
Globus Medical Reports Fourth Quarter and Full Year 2024 Results
AUDUBON, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the fourth quarter and year ...